MRS Imaging as Complement to MRI in the Post‐treatment Follow‐up of Glial Brain Tumors
MRS and MRSI provide valuable metabolic information that complements MRI in the post-treatment evaluation of glial brain tumors. These techniques enhance the detection of tumor recurrence, progression, and radiation necrosis, thereby supporting clinical decision-making and optimizing patient management.
Authors
- Nicolas Magné (ORCID: https://orcid.org/0000-0001-6556-063X)
- Cesar Rodriguez
- Gina Malaver
- Pablo Moreno‐Acosta
- Trinidad González Padín
- German Dario Diaz
- Charan Singh (ORCID: https://orcid.org/0000-0002-1630-3183)
- Wafa Bouleftour (ORCID: https://orcid.org/0000-0002-8485-9386)
- Óscar Gamboa
- Pedro Penagos
- Camilo Zubieta
- Josep Balart
- Cristian Caicedo
Institutions
- Fundación para la Investigación, Docencia y Prevención del Cáncer (AR)
- CorpoGen (Colombia) (CO)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.21873/cdp.10478
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)
- Instituto Nacional de Cancerología